These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 25064584

  • 21. Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.
    Zhou X, Li C, Xu W, Chen J.
    PLoS One; 2012; 7(7):e40424. PubMed ID: 22792312
    [Abstract] [Full Text] [Related]

  • 22. Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease.
    Chierchia SL.
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S19-21. PubMed ID: 11286302
    [Abstract] [Full Text] [Related]

  • 23. Cardioprotective effects of trimetazidine: a review.
    Marzilli M.
    Curr Med Res Opin; 2003 Feb; 19(7):661-72. PubMed ID: 14606990
    [Abstract] [Full Text] [Related]

  • 24. Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities.
    Bucci M, Borra R, Någren K, Maggio R, Tuunanen H, Oikonen V, Del Ry S, Viljanen T, Taittonen M, Rigazio S, Giannessi D, Parkkola R, Knuuti J, Nuutila P, Iozzo P.
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E105-12. PubMed ID: 21505146
    [Abstract] [Full Text] [Related]

  • 25. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 26. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 05; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 27. [Ischemic heart disease and left ventricular dysfunction: the role of trimetazidine].
    Belardinelli R.
    Ital Heart J; 2004 Mar 05; 5 Suppl 2():23S-28S. PubMed ID: 15074774
    [Abstract] [Full Text] [Related]

  • 28. Metabolic energy metabolism in diabetes: therapeutic implications.
    Pogatsa G.
    Coron Artery Dis; 2001 Feb 05; 12 Suppl 1():S29-33. PubMed ID: 11286305
    [Abstract] [Full Text] [Related]

  • 29. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Gao D, Ning N, Niu X, Hao G, Meng Z.
    Heart; 2011 Feb 05; 97(4):278-86. PubMed ID: 21134903
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
    Fidaleo M, Arnauld S, Clémencet MC, Chevillard G, Royer MC, De Bruycker M, Wanders RJ, Athias A, Gresti J, Clouet P, Degrace P, Kersten S, Espeel M, Latruffe N, Nicolas-Francès V, Mandard S.
    Biochimie; 2011 May 05; 93(5):876-91. PubMed ID: 21352884
    [Abstract] [Full Text] [Related]

  • 34. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov 05; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 35. Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review.
    Pușcaș A, Ștefănescu R, Vari CE, Ősz BE, Filip C, Bitzan JK, Buț MG, Tero-Vescan A.
    Int J Mol Sci; 2024 Jan 28; 25(3):. PubMed ID: 38338885
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
    Kota SK, Kota SK, Jammula S, Panda S, Modi KD.
    Diabetes Technol Ther; 2011 Nov 28; 13(11):1155-60. PubMed ID: 21751873
    [Abstract] [Full Text] [Related]

  • 38. Effects of chronic trimetazidine treatment on myocardial preconditioning in anesthetized rats.
    Kara AF, Demiryürek S, Celik A, Tarakçioğlu M, Demiryürek AT.
    Fundam Clin Pharmacol; 2006 Oct 28; 20(5):449-59. PubMed ID: 16968415
    [Abstract] [Full Text] [Related]

  • 39. Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Am J Cardiol; 2006 Sep 04; 98(5A):25J-33J. PubMed ID: 16931203
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.